Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Neuromuscular Junction01:19

The Neuromuscular Junction

18.7K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
18.7K
Compounds Essential to Human Function01:25

Compounds Essential to Human Function

10.1K
The human body is composed of cells that are fundamentally made up of several different molecules. These molecules are essential to carry out all physiological processes in the body and are broadly classified into organic and inorganic based on their chemical structures.
Inorganic Compounds Essential to Human Functioning
Inorganic compounds essential to human functioning include water, salts, acids, and bases. These compounds are inorganic, i.e., they do not have a carbon-hydrogen bond. Water...
10.1K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

5.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.0K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

792
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
792
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

2.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.9K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

965
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
965

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive matrix stiffening of tyramine-modified silk fibroin hydrogels governs stage-specific pulmonary fibroblast activation.

bioRxiv : the preprint server for biology·2026
Same author

Modeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues.

Bioactive materials·2026
Same author

Scalable longitudinal imaging and transcriptomics of cells in dynamic enclosures.

bioRxiv : the preprint server for biology·2026
Same author

Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis.

EXO : beyond the cell·2026
Same author

A Simple, Robust Method for Cellular Electrical Interfacing Using Molecular Patterning.

ACS applied materials & interfaces·2026
Same author

Avenues for optimization of cardiac therapeutics by minimally invasive delivery.

Acta biomaterialia·2026
Same journal

Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78.

Theranostics·2026
Same journal

Ion-Responsive Microneedles Delivering Subtype-Specific Mitochondrial Extracellular Vesicles from HEY1⁺ Cardiomyocytes for Cardiac Repair in Bama Minipigs with Myocardial Ischemia-Reperfusion Injury.

Theranostics·2026
Same journal

Mechano-immune interactions in musculoskeletal aging: Mechanisms and translational perspectives.

Theranostics·2026
Same journal

Peripheral blood immune profiling reveals key signatures in newly diagnosed NK/T cell lymphoma patients.

Theranostics·2026
Same journal

Sonogenetics for precision medicine: from molecular toolkit to clinical translation.

Theranostics·2026
Same journal

Programmable pH-responsive DNA inter-strand matching (PRISM) for precision molecular band-pass actuation.

Theranostics·2026
See all related articles

Related Experiment Video

Updated: Jan 27, 2026

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.8K

Quantification of human neuromuscular function through optogenetics.

Olaia F Vila1, Sebastien G M Uzel2,3, Stephen P Ma1

  • 1Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA.

Theranostics
|March 15, 2019
PubMed
Summary
This summary is machine-generated.

Researchers developed a human patient-specific engineered neuromuscular junction model. This advanced system enables real-time functional analysis for studying neuromuscular diseases and accelerating drug discovery.

Keywords:
Induced Pluripotent Stem CellsMyasthenia GravisNeuromuscular JunctionsTissue Engineering

More Related Videos

Optogenetic Functional MRI
06:06

Optogenetic Functional MRI

Published on: April 19, 2016

15.4K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.7K

Related Experiment Videos

Last Updated: Jan 27, 2026

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.8K
Optogenetic Functional MRI
06:06

Optogenetic Functional MRI

Published on: April 19, 2016

15.4K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.7K

Area of Science:

  • Biomedical Engineering
  • Neuroscience
  • Regenerative Medicine

Background:

  • Traditional studies of neuromuscular diseases rely on animal models, which present challenges in translating findings to human clinical trials due to inter-species differences.
  • Tissue-engineered models offer a promising alternative for studying human physiology in controlled in vitro settings.

Purpose of the Study:

  • To develop the first human patient-specific tissue-engineered model of the neuromuscular junction (NMJ).
  • To enable quantitative, user-independent measurements of NMJ function for research and drug screening.

Main Methods:

  • Integration of stem cell technology, tissue engineering, optogenetics, microfabrication, and advanced image processing.
  • Development of custom hardware and software for precise NMJ function assessment.
  • Creation of patient-specific in vitro models.

Main Results:

  • Demonstrated the model's utility for real-time characterization of functional changes in physiological and pathological states.
  • Successfully established a system for quantitative, repeated measurements of NMJ function.
  • Validated the model for both basic research and translational applications.

Conclusions:

  • The developed system provides a powerful tool for studying human neuromuscular diseases.
  • This patient-specific model holds significant potential for high-throughput drug screening and personalized medicine.
  • Enables the extraction of crucial quantitative functional data from human-derived systems.